ResMed | RMD - Selling And Administration Expenses



ResMed reported $265.12M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Ansell USD 104.45M 115.95M Jun/2024
AtriCure USD 78.39M 2.34M Jun/2025
Baxter International USD 718M 15M Jun/2025
Cochlear AUD 470M 4.4M Dec/2024
Cooper Companies USD 421.7M 22.7M Jul/2025
CSL USD 1.18B 201M Dec/2024
Dexcom USD 328M 17.9M Jun/2025
Edwards Lifesciences USD 502M 36.3M Jun/2025
Fisher Paykel Healthcare NZD 136.95M 123.55M Mar/2025
Globus Medical USD 303.62M 60.82M Jun/2025
Haemonetics USD 91.24M 23.89M Jun/2025
Hologic USD 251.3M 15.1M Jun/2025
Idexx Laboratories USD 259.79M 12M Jun/2025
Insulet USD 253.3M 7.3M Jun/2025
Integra LifeSciences USD 179.89M 15.88M Jun/2025
Intuitive Surgical USD 561.2M 2.2M Jun/2025
Masimo USD 138.9M 19.5M Jun/2025
Medtronic USD 2.81B 106M Jul/2025
Philips EUR 1.24B 9M Jun/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 265.12M 19.82M Jun/2025
Sigma Healthcare AUD 140.17M 5.4M Jul/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Steris USD 353.8M 19.9M Jun/2025
Teleflex USD 215.08M 7.63M Jun/2025
Thermo Fisher Scientific USD 1.78B 58M Jun/2025